Vaccination of Triple Negative Breast Cancer Patients

Clinical trial NCT02938442 · COMPLETED

Trial details

NCT number: NCT02938442
Sponsor: University of Arkansas
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Breast Neoplasms

Start date: 2019-01-25
Primary completion: 2023-01-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.